TY - JOUR
T1 - Enhanced Gi signaling selectively negates β 2-adrenergic receptor (AR)- but not β1-AR-mediated positive inotropic effect in myocytes from failing rat hearts
AU - Xiao, Rui Ping
AU - Zhang, Sheng Jun
AU - Chakir, Khalid
AU - Avdonin, Pavel
AU - Zhu, Weizhong
AU - Bond, Richard A.
AU - Balke, C. William
AU - Lakatta, Edward G.
AU - Cheng, Heping
PY - 2003/9/30
Y1 - 2003/9/30
N2 - Background - Myocardial contractile response to β1- and β2-adrenergic receptor (AR) stimulation is severely impaired in chronic heart failure, in which Gi signaling and the ratio of β2/β1 are often increased. Because β 2-AR but not β1-AR couples to Gs and Gi with the Gi coupling negating the G s-mediated contractile response, we determined whether the heart failure-associated augmentation of Gi signaling contributes differentially to the defects of these β-AR subtypes and, if so, whether inhibition of Gi or selective activation of β 2-AR/Gs by ligands restores β2-AR contractile response in the failing heart. Methods and Results - Cardiomyocytes were isolated from 18- to 24-month-old failing spontaneously hypertensive (SHR) or age-matched Wistar-Kyoto (WKY) rat hearts. In SHR cardiomyocytes, either β-AR subtype-mediated inotropic effect was markedly diminished, whereas Gi proteins and the β2/β1 ratio were increased. Disruption of Gi signaling by pertussis toxin (PTX) enabled β2- but not β1-AR to induce a full positive inotropic response in SHR myocytes. Furthermore, screening of a panel of β2-AR ligands revealed that the contractile response mediated by most β2-AR agonists, including zinterol, salbutamol, and procaterol, was potentiated by PTX, indicating concurrent Gs and Gi activation. In contrast, fenoterol, another β 2-AR agonist, induced a full positive inotropic effect in SHR myocytes even in the absence of PTX. Conclusions - We conclude that enhanced Gi signaling is selectively involved in the dysfunction of β2- but not β1-AR in failing SHR hearts and that disruption of Gi signaling by PTX or selective activation of β2-AR/Gs signaling by fenoterol restores the blunted β2-AR contractile response in the failing heart.
AB - Background - Myocardial contractile response to β1- and β2-adrenergic receptor (AR) stimulation is severely impaired in chronic heart failure, in which Gi signaling and the ratio of β2/β1 are often increased. Because β 2-AR but not β1-AR couples to Gs and Gi with the Gi coupling negating the G s-mediated contractile response, we determined whether the heart failure-associated augmentation of Gi signaling contributes differentially to the defects of these β-AR subtypes and, if so, whether inhibition of Gi or selective activation of β 2-AR/Gs by ligands restores β2-AR contractile response in the failing heart. Methods and Results - Cardiomyocytes were isolated from 18- to 24-month-old failing spontaneously hypertensive (SHR) or age-matched Wistar-Kyoto (WKY) rat hearts. In SHR cardiomyocytes, either β-AR subtype-mediated inotropic effect was markedly diminished, whereas Gi proteins and the β2/β1 ratio were increased. Disruption of Gi signaling by pertussis toxin (PTX) enabled β2- but not β1-AR to induce a full positive inotropic response in SHR myocytes. Furthermore, screening of a panel of β2-AR ligands revealed that the contractile response mediated by most β2-AR agonists, including zinterol, salbutamol, and procaterol, was potentiated by PTX, indicating concurrent Gs and Gi activation. In contrast, fenoterol, another β 2-AR agonist, induced a full positive inotropic effect in SHR myocytes even in the absence of PTX. Conclusions - We conclude that enhanced Gi signaling is selectively involved in the dysfunction of β2- but not β1-AR in failing SHR hearts and that disruption of Gi signaling by PTX or selective activation of β2-AR/Gs signaling by fenoterol restores the blunted β2-AR contractile response in the failing heart.
KW - Contractility
KW - Heart failure
KW - Proteins
KW - Receptors, adrenergic, beta
UR - http://www.scopus.com/inward/record.url?scp=0141618295&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.0000087595.17277.73
DO - 10.1161/01.CIR.0000087595.17277.73
M3 - Article
C2 - 12975249
AN - SCOPUS:0141618295
SN - 0009-7322
VL - 108
SP - 1633
EP - 1639
JO - Circulation
JF - Circulation
IS - 13
ER -